List of APT Therapeutics patents | 5 results

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7247300 Therapeutic use of soluble CD39L3	Patent 7247300 was granted and assigned to APT Therapeutics on July, 2007 by the United States Patent and Trademark Office.	APT Therapeutics	United States Patent and Trademark Office	7247300	July 24, 2007
‌ US Patent 8771683 Therapeutic apyrase constructs, apyrase agents, and production methods	Patent 8771683 was granted and assigned to APT Therapeutics on July, 2014 by the United States Patent and Trademark Office.	APT Therapeutics	United States Patent and Trademark Office	8771683	July 8, 2014
‌ US Patent 7390485 Design and therapeutic use of adpase enhanced apyrases	Patent 7390485 was granted and assigned to APT Therapeutics on June, 2008 by the United States Patent and Trademark Office.	APT Therapeutics	United States Patent and Trademark Office	7390485	June 24, 2008
‌ US Patent 8535662 Apyrase therapy for bleeding conditions	Patent 8535662 was granted and assigned to APT Therapeutics on September, 2013 by the United States Patent and Trademark Office.	APT Therapeutics	United States Patent and Trademark Office	8535662	September 17, 2013
‌ US Patent 8021866 Therapeutic use of ADPase enhanced apyrases	Patent 8021866 was granted and assigned to APT Therapeutics on September, 2011 by the United States Patent and Trademark Office.	APT Therapeutics	United States Patent and Trademark Office	8021866	September 20, 2011